Langerhans-cell histiocytosis 'insight into DC biology'

Trends in Immunology

Volumn 24, Issue 4, 2003, Pages 190-196

  Laman, Jon D ^a   Leenen, Pieter J M ^a   Annels, Nicola E ^b   Hogendoorn, Pancras C W ^b   Egeler, R Maarten ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE;

CARCINOGENESIS; CELL ACTIVATION; CELL CYCLE; CELL INTERACTION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; CYTOLOGY; DENDRITIC CELL; GRANULOMATOUS INFLAMMATION; HISTIOCYTOSIS; HUMAN; IMMUNOPATHOLOGY; LANGERHANS CELL; MICROENVIRONMENT; MITOSIS INHIBITION; NEOPLASM; PHENOTYPE; REVIEW; T LYMPHOCYTE;

EID: 0037385291     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(03)00063-2     Document Type: Review

References (39)

1. Caligaris-Cappio F. How immunology is reshaping clinical disciplines: the example of haematology. Lancet. 358:2001;49-55.
2. Favara B.E., et al. Contemporary classification of histiocytic disorders. The WHO committee on histiocytic/reticulum-cell proliferations. Reclassification working group of the histiocyte society. Med. Pediatr. Oncol. 29:1997;157-166.
3. Pileri S.A., et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. 41:2002;1-29.
4. Egeler R.M., D'Angio G.J. Langerhans-cell histiocytosis. J. Pediatr. 127:1995;1-11.
5. Arceci R.J., et al. Atypical cellular disorders. Hematology (Am. Soc. Hematol. Educ. Program). 2002;297-314.
6. Aricò M., Danesino C. Langerhans'-cell histiocytosis: is there a role for genetics? Haematologica. 86:2001;1009-1014.
7. Vassallo R., et al. Pulmonary Langerhans'-cell histiocytosis. N. Engl. J. Med. 342:2000;1969-1978.
8. Aricò M., Egeler R.M. Clinical aspects of Langerhans-cell histiocytosis. Hematol. Oncol. Clin. North Am. 12:1998;247-258.
9. Vassallo R., et al. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N. Engl. J. Med. 346:2002;484-490.
10. Schmitz L., Favara B.E. Nosology and pathology of Langerhans-cell histiocytosis. Hematol. Oncol. Clin. North Am. 12:1998;221-246.
11. Geissmann F., et al. Differentiation of Langerhans cells in Langerhans-cell histiocytosis. Blood. 97:2001;1241-1248.
12. Lutz B.M., Schuler G. Immature semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23:2002;445-449.
13. Ricciardi-Castagnoli P., Granucci F. Interpretation of the complexity of innate immune responses by functional genomics. Nat. Rev. Immunol. 2:2002;881-888.
14. Chu T., Jaffe R. The normal Langerhans cell and the LCH cell. Br. J. Cancer. 23:(Suppl.):1994;S4-S10.
15. de Graaf J.H., et al. Expression of cellular adhesion molecules in Langerhans-cell histiocytosis and normal Langerhans cells. Am. J. Pathol. 147:1995;1161-1171.
16. Tazi A., et al. Evidence that Langerhans cells in adult pulmonary Langerhans-cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment. J. Immunol. 163:1999;3511-3515.
17. Egeler R.M., et al. Abundant expression of CD40 and CD40-ligand (CD154) in paediatric Langerhans-cell histiocytosis lesions. Eur. J. Cancer. 36:2000;2105-2110.
18. Egeler R.M., et al. Differential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans-cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood. 94:1999;4195-4201.
19. Kannourakis G., Abbas A. The role of cytokines in the pathogenesis of Langerhans-cell histiocytosis. Br. J. Cancer. 23:(Suppl.):1994;S37-S40.
20. de Graaf J.H., et al. The presence of cytokines in Langerhans'-cell histiocytosis. J. Pathol. 180:1996;400-406.
21. Foss H.D., et al. Monokine expression in Langerhans'-cell histiocytosis and sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). J. Pathol. 179:1996;60-65.
22. Yousem S.A., et al. Pulmonary Langerhans'-cell histiocytosis: molecular analysis of clonality. Am. J. Surg. Pathol. 25:2001;630-636.
23. Willman C.L., McClain K.L. An update on clonality, cytokines and viral etiology in Langerhans-cell histiocytosis. Hematol. Oncol. Clin. North Am. 12:1998;407-416.
24. Aricò M., et al. Familial clustering of Langerhans-cell histiocytosis. Br. J. Haematol. 107:1999;883-888.
25. Betts D.R., et al. Cytogenetic abnormalities in Langerhans-cell histiocytosis. Br. J. Cancer. 77:1998;552-555.
26. Murakami I., et al. Detection of molecular cytogenetic aberrations in Langerhans-cell histiocytosis of bone. Hum. Pathol. 33:2002;555-560.
27. Abdelatif O.M., et al. Enhanced expression of c-myc and h-ras oncogenes in Letterer-Siwe disease. A sequential study using colorimetric in situ hybridization. Arch. Pathol. Lab. Med. 114:1990;1254-1260.
28. Schouten B., et al. Expression of cell cycle related gene products in Langerhans-cell histiocytosis. J. Pediatr. Hematol. Oncol. 24:2002;727-732.
29. Ibsen Bank M., et al. High expression of markers of apoptosis and proliferation in Langerhans-cell histiocytosis. J. Pediatr. Hematol. Oncol. 24:2002;733-738.
30. Hage C., et al. Langerhans'-cell histiocytosis (Histiocytosis X): immunophenotype and growth fraction. Hum. Pathol. 24:1993;840-845.
31. Brabencova E., et al. Langerhans cells in Langerhans-cell granulomatosis are not actively proliferating cells. Am. J. Pathol. 152:1998;1143-1149.
32. Merad M., et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3:2002;1135-1141.
33. Garcia de Vinuesa C., et al. Anti-CD40 antibody enhances responses to polysaccharide without mimicking T-cell help. Eur. J. Immunol. 29:1999;3216-3224.
34. + hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J. Exp. Med. 185:1997;341-349.
35. Grousson J., et al. CD40 ligation alters the cell cycle of differentiating keratinocytes. J. Invest. Dermatol. 114:2000;581-586.
36. Sallusto F., Lanzavecchia A. Understanding dendritic-cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol. Rev. 177:2000;134-140.
37. Shortman K., Liu Y.J. Mouse and human dendritic-cell subtypes. Nat. Rev. Immunol. 2:2002;151-161.
38. Companjen A.R., et al. A modified ex vivo skin organ culture system for functional studies. Arch. Dermatol. Res. 293:2001;184-190.
39. Soilleux E.J., et al. Constitutive and induced expression of DC-SIGN on dendritic-cell and macrophage subpopulations in situ and in vitro. J. Leukoc. Biol. 71:2002;445-457.